# iProtics

Private

Leiden Healthcare & Life Sciences [https://iprotics.eu/](https://iprotics.eu/)

Last Round

Seed

Oct 10, 2024

Total Funding Raised

$850,000

## Company Overview

iProtics is a biotechnology company developing selective immunoproteasome inhibitors to treat hematological cancers and autoimmune disorders.

**Sector**
Healthcare & Life Sciences

**Verticals**  
Biotechnology, Drug Discovery

**Business Model**  
B2B

**Customer Profile**  
Services & Consulting

**AI Layer**  
Non-AI

**Keywords**  
immunoproteasome inhibitor, peptide-based therapy, drug discovery, hematological cancer, autoimmune disorder, biotech startup, pre-clinical development, targeted therapy, oncology research, biotech spin-out, proteasome inhibitor, precision medicine, drug pipeline, biopharma

## Historical Pricing

Historical view of private secondary pricing and transaction trends.

### Unlock Pricing Charts

## Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

### View Momentum History

## iProtics Comparables

Compare iProtics with similar companies based on industry and business-model similarity.

| Company | Similarity | Market Cap |
| --- | --- | --- |
| [IpiNovyx Bio](/content/company/ipinovyx/index.html) | 87% | Unlock |
| [QLi5 Therapeutics GmbH](/content/company/qli5tx/index.html) | 82% | Unlock |
| Aurinia Pharmaceuticals Inc. | 76% | Unlock |
| Comparable company | 50% | Unlock |

## iProtics Funding Rounds

Historical fundraising activity

| Round | Date | Amount Raised | Valuation | Investors | Sources |
| --- | --- | --- | --- | --- | --- |
| Seed | Oct 10, 2024 | Unlock | Unlock | Unlock | Unlock |
| Grant | Mar 20, 2024 | Unlock | Unlock | Unlock | Unlock |
| Accelerator | Sep 9, 2022 | Unlock | Unlock | Unlock | Unlock |

## Key People

**Elmer Maurits**  
CEO Co-founder  
[LinkedIn profile](https://www.linkedin.com/in/elmer-maurits-phd-01b4b943 "LinkedIn profile")

## iProtics Investors

| Investor | Rounds |
| --- | --- |
| [Libertatis Ergo Holding](/content/investor/libertatisergo/index.html) | Seed |
| [Netherlands Organization for Scientific Research](/content/investor/dutch-research-council/index.html) | Grant |
| [Life Sciences @ Work Venture Challenge](/content/investor/lifesciencesatwork/index.html) | Accelerator |

## Market signals

Structured signals derived from secondary market and firmographic data.

- Oct 10, 2024
  
  $380K round led by uniiq

- Mar 20, 2024  
  $220K grant from Netherlands Organization for Scientific Research.

## iProtics Filings

SEC and related filings with document metadata.

| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
| --- | --- | --- | --- | --- | --- | --- |
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |

## Frequently Asked Questions

Common questions about iProtics's valuation, stock price, and market status.

- Is iProtics a public or private company?
- What is the current stock price of iProtics?
- How much is iProtics worth (valuation)?
- Can I buy iProtics stock?
- When was iProtics's last funding round?
- Who are the main investors in iProtics?
- Will iProtics IPO soon?
- How can I track iProtics secondary market activity?

## Firmographic Details
**Headquarters** Leiden  
**Employee Range** 2  
**Year Founded** 2024  
**Last Funding** Oct 10, 2024